The outsourcing tre The Peptide and Oligonucleotide CDMO Market is experiencing accelerated growth, driven by advancements in biotechnology, increased demand for biopharmaceuticals, and the shift toward personalized medicine. Expected to grow at a CAGR of 12.5% from 2025 to 2031, the market size will expand from US$ XX million in 2024 to US$ XX million by 2031. This growth presents valuable...